Total Payments
$1.4M
2024 Payments
$72,466
Companies
46
Transactions
2,057
Medicare Patients
3,162
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$743,048 (51.9%)
Consulting$549,559 (38.4%)
Travel$90,681 (6.3%)
Food & Beverage$38,177 (2.7%)
Research$10,393 (0.7%)
Education$1,124 (0.1%)
Gifts$16.99 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $694,983 | 281 | 48.5% |
| Consulting Fee | $549,559 | 127 | 38.4% |
| Travel and Lodging | $90,681 | 496 | 6.3% |
| Honoraria | $48,065 | 21 | 3.4% |
| Food and Beverage | $38,177 | 1,107 | 2.7% |
| Unspecified | $10,393 | 4 | 0.7% |
| Education | $1,124 | 20 | 0.1% |
| Gift | $16.99 | 1 | 0.0% |
Payments by Type
General
$1.4M
2,053 transactions
Research
$10,393
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $855,122 | 902 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $147,184 | 196 | $0 (2024) |
| Acorda Therapeutics, Inc | $115,205 | 132 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $100,438 | 26 | $0 (2024) |
| Kyowa Kirin, Inc. | $68,371 | 82 | $0 (2023) |
| US WorldMeds, LLC | $47,218 | 148 | $0 (2020) |
| Adamas Pharmaceuticals, Inc. | $32,056 | 82 | $0 (2021) |
| MDD US Operations, LLC | $27,017 | 115 | $0 (2024) |
| ABBVIE INC. | $10,245 | 123 | $0 (2024) |
| Eli Lilly and Company | $9,520 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72,466 | 157 | Teva Pharmaceuticals USA, Inc. ($63,944) |
| 2023 | $171,493 | 233 | Teva Pharmaceuticals USA, Inc. ($152,537) |
| 2022 | $88,590 | 200 | Teva Pharmaceuticals USA, Inc. ($61,478) |
| 2021 | $153,685 | 189 | Teva Pharmaceuticals USA, Inc. ($91,493) |
| 2020 | $245,872 | 155 | Amneal Pharmaceuticals LLC ($100,000) |
| 2019 | $214,593 | 338 | Teva Pharmaceuticals USA, Inc. ($102,667) |
| 2018 | $235,064 | 359 | Teva Pharmaceuticals USA, Inc. ($130,943) |
| 2017 | $251,239 | 426 | Teva Pharmaceuticals USA, Inc. ($159,773) |
All Payment Transactions
2,057 individual payment records from CMS Open Payments — Page 1 of 83
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Central Nervous System | ||||||
| 12/06/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: Central Nervous System | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/13/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Musculoskeletal | ||||||
| 11/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,688.00 | General |
| Category: Central Nervous System | ||||||
| 11/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | Cash or cash equivalent | $1,145.29 | General |
| Category: Central Nervous System | ||||||
| 11/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $53.21 | General |
| Category: Central Nervous System | ||||||
| 11/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: AMANTADINE | ||||||
| 11/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: AMANTADINE | ||||||
| 11/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: AMANTADINE | ||||||
| 10/31/2024 | Medtronic, Inc. | SENSIGHT (Device) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 10/31/2024 | Medtronic, Inc. | SENSIGHT (Device) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/31/2024 | Medtronic, Inc. | SENSIGHT (Device) | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 10/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Central Nervous System | ||||||
| 10/10/2024 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/08/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Neurology | ||||||
| 10/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: AMANTADINE | ||||||
| 10/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Neuropsychiatry | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EFFECT OF LY3154207 ON COGNITION IN MILD TO MODERATE PARKINSONS DISEASE DEMENTIA PDD - THE PRESENCE STUDY | Eli Lilly and Company | $9,520 | 2 |
| ACP-103-015 | ACADIA Pharmaceuticals Inc | $819.00 | 1 |
| Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease | Biogen, Inc. | $54.40 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 803 | 59,392 | $1.1M | $428,224 |
| 2022 | 18 | 833 | 65,705 | $1.2M | $461,848 |
| 2021 | 18 | 841 | 63,071 | $1.2M | $458,642 |
| 2020 | 18 | 685 | 63,077 | $1.1M | $408,636 |
Total Patients
3,162
Total Services
251,245
Medicare Billing
$1.8M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 63 | 57,801 | $580,000 | $286,326 | 49.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 135 | 264 | $96,888 | $35,462 | 36.6% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 41 | 141 | $139,656 | $18,982 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 195 | $53,040 | $17,920 | 33.8% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 32 | 88 | $79,325 | $13,968 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 187 | $33,473 | $12,151 | 36.3% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 59 | 186 | $21,762 | $12,023 | 55.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 71 | 71 | $37,346 | $11,943 | 32.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 78 | 204 | $19,287 | $5,233 | 27.1% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 26 | 31 | $12,524 | $3,241 | 25.9% |
| 64646 | Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles | Office | 2023 | 14 | 42 | $21,252 | $2,975 | 14.0% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 12 | 32 | $17,920 | $2,944 | 16.4% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 12 | 41 | $6,519 | $1,650 | 25.3% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 17 | 20 | $5,640 | $1,496 | 26.5% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 26 | 32 | $3,808 | $909.44 | 23.9% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 22 | 46 | $6,808 | $679.50 | 10.0% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2023 | 11 | 11 | $1,309 | $321.97 | 24.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 65 | 63,830 | $638,300 | $306,522 | 48.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 136 | 301 | $110,467 | $40,744 | 36.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 43 | 149 | $144,210 | $23,702 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 162 | $44,064 | $15,258 | 34.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 60 | 196 | $22,932 | $13,237 | 57.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 181 | $32,399 | $11,306 | 34.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 59 | 59 | $31,034 | $9,803 | 31.6% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 34 | 82 | $72,675 | $9,253 | 12.7% |
About Dr. Rajeev Kumar, MD
Dr. Rajeev Kumar, MD is a Neurology healthcare provider based in Englewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447343751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rajeev Kumar, MD has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $72,466 received in 2024. These payments were reported across 2,057 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($694,983).
As a Medicare-enrolled provider, Kumar has provided services to 3,162 Medicare beneficiaries, totaling 251,245 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Englewood, CO
- Active Since 10/02/2006
- Last Updated 10/13/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1447343751
Products in Payments
- AUSTEDO (Drug) $591,450
- Austedo XR (Drug) $195,795
- NUPLAZID (Drug) $147,184
- INBRIJA (Drug) $115,170
- NOURIANZ (Drug) $54,946
- SD809-HD (Drug) $38,350
- GOCOVRI (Drug) $32,391
- SD809-TD (Drug) $28,155
- Xadago (Drug) $17,152
- APOKYN (Drug) $16,640
- MYOBLOC (Biological) $14,061
- Nourianz (Drug) $8,443
- BOTOX (Biological) $6,220
- ISTRADEFYLLINE (Drug) $4,982
- INGREZZA (Drug) $1,751
- NORTHERA (Drug) $1,728
- MYOBLOC (Drug) $1,186
- XADAGO (Drug) $1,120
- Duopa (Drug) $917.14
- DUOPA (Drug) $857.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Englewood
Dr. Marc Treihaft, Md, MD
Neurology — Payments: $672,184
Neurology $672,184
Beverly Gilder, Md, MD
Neurology — Payments: $666,331
Neurology $666,331
Cori Millen, D.o, D.O
Neurology — Payments: $325,077
Neurology $325,077
Rikki Racela, Md, MD
Neurology — Payments: $134,214
Neurology $134,214
Monique Giroux, Md, MD
Neurology — Payments: $85,901
Neurology $85,901
Dr. Aaron Haug, M.d, M.D
Neurology — Payments: $85,576
Neurology $85,576